[FG] Schmid Yasmin

Klaiber, A. et al. (2024) ‘Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects’, Translational Psychiatry, 14(1). Available at: https://doi.org/10.1038/s41398-024-03116-2.

Schmid, Y. and Bershad, A.K. (2024) ‘Altered states and social bonds: Effects of MDMA and serotonergic psychedelics on social behavior as a mechanism underlying substance-assisted therapy’, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging [Preprint]. Available at: https://doi.org/10.1016/j.bpsc.2024.02.001.

Aicher, H.D., Schmid, Y. and Gasser, P. (2024) ‘Psychedelics-assisted psychotherapy: Experiences with the limited medical use of LSD, MDMA, and psilocybin in Switzerland’, Psychotherapie, null. Available at: https://doi.org/10.1007/s00278-024-00711-y.

Lewis V et al. (2023) ‘A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.’, Cell reports, 42(3), p. 112203. Available at: https://doi.org/10.1016/j.celrep.2023.112203.

Angerer, V. et al. (2023) ‘Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study’, Drug Testing and Analysis, null. Available at: https://doi.org/10.1002/dta.3622.

Miró, Òscar et al. (2023) ‘Severity of emergency department presentations due to acute drug toxicity in Europe: A longitudinal analysis over a 6-year period (2014-2019) stratified by sex’, European Journal of Emergency Medicine, 30, pp. 21–31. Available at: https://doi.org/10.1097/mej.0000000000000978.

Noseda, Roberta et al. (2023) ‘Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12185970.

Noseda,Roberta et al. (2023) ‘Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study ’, J Clin Med, 12(18). Available at: https://doi.org/10.3390/jcm12185970.

Vallersnes, O.M. et al. (2023) ‘Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries’, International Journal of Emergency Medicine, 16. Available at: https://doi.org/10.1186/s12245-023-00566-1.

Stucky S et al. (2023) Krampfanfall nach schwerer Asthmaexazerbation. 23, pp. 1092–1094. Available at: https://doi.org/10.4414/smf.2023.09090.

Crulli, B. et al. (2022) ‘Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019’, Clinical Toxicology, 60, pp. 1318–1327. Available at: https://doi.org/10.1080/15563650.2022.2137524.

Dongre, Kanchan et al. (2022) ‘Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists’, Global Cardiology Science and Practice, 2022. Available at: https://doi.org/10.21542/gcsp.2022.21.

Heier, Eva-Carina et al. (2022) ‘Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs’, European Journal of Emergency Medicine, 29, pp. 291–300. Available at: https://doi.org/10.1097/mej.0000000000000932.

Müller, Felix et al. (2022) ‘Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants’, Psychopharmacology, 239(6), pp. 1933–1943. Available at: https://doi.org/10.1007/s00213-022-06066-z.

Schmid Y et al. (2022) ‘Age- and sex-related differences in clinical presentations due to acute cannabis toxicity at European Emergency Departments’, Clinical Toxicology, 60(S1), pp. 13–14. Available at: https://doi.org/doi.org/10.1080/15563650.2022.2054576.

Schmid Y et al. (2022) ‘Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex’, Clinical Toxicology, 60(8), pp. 912–919. Available at: https://doi.org/10.1080/15563650.2022.2060116.

Halberstadt A et al. (2022) ‘Investigation of the Pharmacological Properties of 2-Br-LSD, a Non-Hallucinogenic LSD Analog’, 47. Available at: https://doi.org/https://doi.org/10.1038/s41386-022-01485-0.

Layne KA et al. (2021) ‘Acute toxicity related to misuse (nonmedical use) of tramadol: Experience of the European Drug Emergencies Network Plus.’, British journal of clinical pharmacology, 87(4), pp. 1668–1675. Available at: https://doi.org/10.1111/bcp.14408.

Schmid Y et al. (2021) ‘Acute subjective effects in LSD- and MDMA-assisted psychotherapy.’, Journal of psychopharmacology (Oxford, England), 35(4), pp. 362–374. Available at: https://doi.org/10.1177/0269881120959604.

Noseda R et al. (2021) ‘MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014-2017.’, Clinical toxicology (Philadelphia, Pa.), 59(2), pp. 131–137. Available at: https://doi.org/10.1080/15563650.2020.1784914.

Vizeli, Patrick et al. (2021) ‘Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis’, Scientific reports, 11(1), p. 10851. Available at: https://doi.org/10.1038/s41598-021-90343-y.

Ioanna Istampoulouoglou and Schmid Y (2021) ‘SOP Paracetamolintoxikation’. Thieme, (3).

Schmid, Yasmin et al. (2020) ‘Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland’, Drug and Alcohol Dependence, 206, p. 107726. Available at: https://doi.org/10.1016/j.drugalcdep.2019.107726.

Suenderhauf, Claudia et al. (2020) ‘Pharmacokinetics and phenotyping properties of the ‘Basel’ phenotyping cocktail combination capsule in healthy male adults’, British journal of clinical pharmacology, 86(2), pp. 352–361. Available at: https://doi.org/10.1111/bcp.14157.

Schmid Y (2020) ‘Psychedelika in der Behandlung von Cluster-Kopfschmerzen’.

Bühler T, Schmid Y and Liechti ME (2019) ‘[Knockout Drugs: Diagnostics in the Emergency Unit and Clinical Practice].’, Praxis, 108(13), pp. 869–876. Available at: https://doi.org/10.1024/1661-8157/a003306.

Wolfe CE et al. (2019) ‘Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set.’, Neurotoxicology, 73, pp. 183–187. Available at: https://doi.org/10.1016/j.neuro.2019.04.003.

Brockhaus L et al. (2019) ‘Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports.’, BMC pharmacology & toxicology, 20(1), p. 9. Available at: https://doi.org/10.1186/s40360-019-0289-7.

Kiene, Klara et al. (2019) ‘Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film’, European Journal of Pharmaceutical Sciences, 135, pp. 77–82. Available at: https://doi.org/10.1016/j.ejps.2019.05.010.

Leuppi-Taegtmeyer, Anne et al. (2019) ‘Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions’, Nephrology, Dialysis, Transplantation, 34(4), pp. 692–702. Available at: https://doi.org/10.1093/ndt/gfy285.

Schmid, Yasmin et al. (2019) ‘Sex differences in the pharmacology of itch therapies - a narrative review’, Current Opinion in Pharmacology, 46, pp. 122–142. Available at: https://doi.org/10.1016/j.coph.2019.05.008.

Scholz, Irene et al. (2019) ‘Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distribution’, Swiss Medical Weekly, 149, p. w20056. Available at: https://doi.org/10.4414/smw.2019.20056.

Boxler, Martina I. et al. (2018) ‘Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes’, Journal of proteome research, 17(8), pp. 2900–2907. Available at: https://doi.org/10.1021/acs.jproteome.8b00438.

Dolder, Patrick C. et al. (2018) ‘Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects’, Psychopharmacology, 235(2), pp. 467–479. Available at: https://doi.org/10.1007/s00213-017-4650-5.

Schmidt, A. et al. (2018) ‘Acute LSD effects on response inhibition neural networks’, Psychological Medicine, 48(9), pp. 1464–1473. Available at: https://doi.org/10.1017/s0033291717002914.

Schmidt, André et al. (2018) ‘Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing’, The international journal of neuropsychopharmacology, 21(4), pp. 345–354. Available at: https://doi.org/10.1093/ijnp/pyx112.

Schmid, Yasmin and Liechti, Matthias E. (2018) ‘Long-lasting subjective effects of LSD in normal subjects’, Psychopharmacology, 235(2), pp. 535–545. Available at: https://doi.org/10.1007/s00213-017-4733-3.

Boxler MI et al. (2017) ‘First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects.’, Journal of proteome research. 09.08.2017, 16(9), pp. 3310–3320. Available at: https://doi.org/10.1021/acs.jproteome.7b00294.

Dolder, Patrick C. et al. (2017) ‘Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images’, Psychopharmacology, 234(1), pp. 41–51. Available at: https://doi.org/10.1007/s00213-016-4431-6.

Dolder, Patrick C. et al. (2017) ‘Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects’, Clinical Pharmacokinetics, 56(10), pp. 1219–1230. Available at: https://doi.org/10.1007/s40262-017-0513-9.

Liechti, Matthias E., Dolder, Patrick C. and Schmid, Yasmin (2017) ‘Alterations of consciousness and mystical-type experiences after acute LSD in humans’, Psychopharmacology, 234(9-10), pp. 1499–1510. Available at: https://doi.org/10.1007/s00213-016-4453-0.

Müller, F. et al. (2017) ‘Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects’, Translational Psychiatry, 7(4), p. e1084. Available at: https://doi.org/10.1038/tp.2017.54.

Schmidt, André et al. (2017) ‘Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects’, International Journal of Neuropsychopharmacology, 20(9), pp. 712–720. Available at: https://doi.org/10.1093/ijnp/pyx037.

Steuer, Andrea E. et al. (2017) ‘Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans’, Drug testing and analysis, 9(5), pp. 788–797. Available at: https://doi.org/10.1002/dta.2042.

Vizeli, Patrick et al. (2017) ‘Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects’, European Neuropsychopharmacology, 27(3), pp. 232–238. Available at: https://doi.org/10.1016/j.euroneuro.2017.01.008.

Liechti ME et al. (2017) ‘Pharmacokinetics and pharmacodynamics of two doses of oral LSD in healthy subjects.’, 55(5). Available at: https://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1309792.

Vizeli P, Schmid Y and Liechti ME (2017) ‘Pharmacogenetics of 3,4-methylenedioxymethamphetamine (MDMA): cytochrome P450 polymorphisms moderate pharmacokinetics and pharmacodynamic effects of MDMA in healthy subjects.’, 55(5). Available at: https://doi.org/doi.org/10.1080/15563650.2017.1309792.

Dolder, P.C. et al. (2016) ‘LSD acutely impairs fear recognition and enhances emotional empathy and sociality’, European Neuropsychopharmacology, 26, p. S261. Available at: https://doi.org/10.1016/s0924-977x(16)31139-7.

Dolder, P.C. et al. (2016) ‘Acute dose-response effects of LSD in healthy humans’, European Neuropsychopharmacology, 26, pp. S248–S249. Available at: https://doi.org/10.1016/s0924-977x(16)31119-1.

Schmid, Y. et al. (2016) ‘Cytochrome 2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in healthy subjects’, European Neuropsychopharmacology, 26, pp. S179–S180. Available at: https://doi.org/10.1016/s0924-977x(16)31010-0.

Dolder, Patrick C. et al. (2016) ‘LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality’, Neuropsychopharmacology, 41(11), pp. 2638–46. Available at: https://doi.org/10.1038/npp.2016.82.

Schmid, Yasmin et al. (2016) ‘CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals’, Pharmacogenetics and Genomics, 26, pp. 397–401. Available at: https://doi.org/10.1097/fpc.0000000000000231.

Steuer, Andrea E. et al. (2016) ‘Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans’, PLoS ONE, 11(3), p. e0150955. Available at: https://doi.org/10.1371/journal.pone.0150955.

Strajhar, Petra et al. (2016) ‘Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects’, Journal of Neuroendocrinology, 28(3), p. 12374. Available at: https://doi.org/10.1111/jne.12374.

Dolder PC et al. (2016) ‘Acute dose-response of LSD in healthy subjects’, 26(S2).

Schmid Y et al. (2016) ‘CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in a controlled study in healthy subjects’, 26(S2).

Dolder, Patrick C et al. (2015) ‘Pharmacokinetics and concentration-effect relationship of oral LSD in humans’, International journal of neuropsychopharmacology, 19(1), p. pyv072. Available at: https://doi.org/10.1093/ijnp/pyv072.

Schmid, Yasmin et al. (2015) ‘Acute effects of lysergic acid diethylamide in healthy subjects’, Biological psychiatry, 78(8), pp. 544–53. Available at: https://doi.org/10.1016/j.biopsych.2014.11.015.

Schmid, Yasmin et al. (2015) ‘Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships’, European neuropsychopharmacology, 25(1), pp. 17–25. Available at: https://doi.org/10.1016/j.euroneuro.2014.11.020.

Schmid, Yasmin et al. (2015) ‘Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects’, Journal of pharmacology and experimental therapeutics, 353(1), pp. 102–111. Available at: https://doi.org/10.1124/jpet.114.222356.

Steuer, Andrea E. et al. (2015) ‘Chiral plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine and its phase I and II metabolites following controlled administration to humans’, Drug metabolism and disposition, 43(12), pp. 1864–1871. Available at: https://doi.org/10.1124/dmd.115.066340.

Dolder PC et al. (2015) ‘Pharmacology of LSD in humans.’, (29).

Schmid Y, Dolder PC and Liechti ME (2015) ‘Acute autonomic and psychotropic effects of LSD in healthy subject in a placebo-controlled study’, 53(4). Available at: https://doi.org/doi: 10.3109/15563650.2015.1024953.

Hysek, C. M. et al. (2014) ‘MDMA enhances emotional empathy and prosocial behavior’, Social cognitive and affective neuroscience, 9(11), pp. 1645–52. Available at: https://doi.org/10.1093/scan/nst161.

Hysek, C. M. et al. (2014) ‘Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination’, International journal of neuropsychopharmacology, 17(3), pp. 371–81. Available at: https://doi.org/10.1017/s1461145713001132.

Schmid, Yasmin et al. (2014) ‘Differential effects of MDMA and methylphenidate on social cognition’, Journal of psychopharmacology, 28(9), pp. 847–56. Available at: https://doi.org/10.1177/0269881114542454.

Seibert, Julia et al. (2014) ‘Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects’, Neuroendocrinology, 100(1), pp. 17–25. Available at: https://doi.org/10.1159/000364879.

Schmid Y, Hysek CM and Liechti ME (2014) ‘Acute effects of methylphenidate in healthy subjects alone and in combination with MDMA’, 52(4). Available at: https://doi.org/doi.org/10.3109/15563650.2014.906213.

Schmid Y, Quednow BB and Liechti ME (2014) ‘Effects of methylphenidate and MDMA (ecstasy) on appraisal of erotic stimuli’. Available at: https://doi.org/ DOI: 10.1016/S0924-977X(14)71117-4.

Hysek, Cédric M et al. (2013) ‘Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans : lost in translation’, British journal of pharmacology, 170(6), pp. 1273–5. Available at: https://doi.org/10.1111/bph.12398.

Hysek, C. et al. (2012) ‘Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans’, British journal of pharmacology, 166(8), pp. 2277–88. Available at: https://doi.org/10.1111/j.1476-5381.2012.01936.x.